MHCC-97H Cells

Unit

3 x 10^6 cells/ml

Cell Type

Tumor Cells

Tissue Type

Liver cancer cell lines

Organism

Human

Donor History

Adult hepatocellular carcinoma

Growth Properties

Adherent

Growth Conditions

Culture medium: DMEM

,

w: 4.5 g/L Glucose

,

w: 4 mM L-Glutamine

,

w: 3.7 g/L NaHCO3

,

w: 1.0 mM Sodium pyruvate (Cytion article number 820300a). Supplements: Supplement the medium with 10% FBS. Dissociation reagent: Accutase. Seeding density: 1.5 to 4 x 10⁴ cells/cm². Freeze medium: As a cryopreservation medium

,

we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability

,

or CM-1 (Cytion catalog number 800100)

,

which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. Incubation atmosphere: 37°C

,

5% CO2

,

humidified atmosphere.

Immortalization Method
Full Information

https://www.cytion.com/MHCC-97H-Cells/305442

SKU: 305442 Kategorie: ,
Mgr. Otakar Fišer
Máte otázky k tomuto produktu? Kontaktujte našeho specialistu.
Mgr. Otakar Fišer
Produktový manažer - Life Science
Popis

The MHCC-97H cell line is a human hepatocellular carcinoma (HCC) model with a high metastatic potential. It was established from the MHCC97 parental line, derived from a male patient with HCC linked to hepatitis B virus (HBV) infection. MHCC-97H has been extensively utilized in studies focusing on cancer metastasis, particularly because it consistently demonstrates spontaneous lung metastases following orthotopic implantation in mouse models. This feature makes it a valuable resource for exploring the mechanisms of HCC progression and metastasis.

MHCC-97H cells exhibit an epithelial morphology and possess key genetic and molecular characteristics contributing to their aggressive metastatic behavior. The line is noted for its upregulation of matrix metalloproteinases (MMP-2 and MMP-9), which facilitate extracellular matrix degradation and promote invasive capabilities. Proteomic analyses have identified several differentially expressed proteins in MHCC-97H compared to its low-metastatic counterpart MHCC-97L, including elevated levels of pyruvate kinase M2 and S100 calcium-binding protein A4. These findings highlight their utility in studying the molecular pathways governing metastasis.

MHCC-97H is used in preclinical research for testing therapeutic strategies targeting metastasis. In vivo models involving this cell line allow researchers to investigate the efficacy of treatments aimed at mitigating metastatic spread, especially to the lungs. Additionally, MHCC-97H aids in the development of biomarkers for predicting HCC aggressiveness and in studying the tumor microenvironment’s role in metastasis. These applications underscore its critical importance in advancing our understanding of hepatocellular carcinoma biology.

O značce

Společnost Cytion vznikla v roce 2004 v německém Heidelbergu s jasným vědeckým posláním: dodávat ověřené lidské a zvířecí buněčné linie bez kontaminace, připravené za přísně kontrolovaných laboratorních podmínek.

Postupně se vypracovala ve spolehlivou buněčnou banku, která slouží akademickým laboratořím, biotechnologickým firmám i farmaceutickým výzkumným týmům po celém světě. Klade přitom důraz na reprodukovatelnost výsledků, přísnou kontrolu kvality a dlouhodobá partnerství.